{
    "organizations": [],
    "uuid": "77d27c808be83e6e4dccc8420cdbfba987c37702",
    "author": "",
    "url": "https://www.reuters.com/article/brief-pfenex-and-nt-pharma-enter-into-a/brief-pfenex-and-nt-pharma-enter-into-a-development-and-license-agreement-for-pfenexs-pf708-therapeutic-equivalent-candidate-to-forteo-idUSFWN1RV0Y4",
    "ord_in_thread": 0,
    "title": "BRIEF-Pfenex And NT Pharma Enter Into A Development And License Agreement For Pfenex's PF708 Therapeutic Equivalent Candidate To Forteo",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 18 (Reuters) - China NT Pharma Group Co Ltd:\n* PFENEX AND NT PHARMA ENTER INTO A DEVELOPMENT AND LICENSE AGREEMENT FOR PFENEX’S PF708 THERAPEUTIC EQUIVALENT CANDIDATE TO FORTEO®\n* PFENEX INC - PFENEX RECEIVED A PAYMENT OF $2.5 MILLION UPON SIGNING OF AGREEMENT\n* PFENEX INC - PFENEX MAY BE ELIGIBLE TO RECEIVE ADDITIONAL PAYMENTS OF UP TO $22.5 MILLION BASED ON ACHIEVEMENT OF DEVELOPMENT, SALES-RELATED MILESTONES\n* PFENEX INC - PFENEX MAY ALSO BE ELIGIBLE TO RECEIVE DOUBLE-DIGIT ROYALTIES ON NET PRODUCT SALES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-19T00:05:00.000+03:00",
    "crawled": "2018-04-19T00:22:19.011+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "china",
        "nt",
        "pharma",
        "group",
        "co",
        "ltd",
        "pfenex",
        "nt",
        "pharma",
        "enter",
        "development",
        "license",
        "agreement",
        "pfenex",
        "pf708",
        "therapeutic",
        "equivalent",
        "candidate",
        "pfenex",
        "inc",
        "pfenex",
        "received",
        "payment",
        "million",
        "upon",
        "signing",
        "agreement",
        "pfenex",
        "inc",
        "pfenex",
        "may",
        "eligible",
        "receive",
        "additional",
        "payment",
        "million",
        "based",
        "achievement",
        "development",
        "milestone",
        "pfenex",
        "inc",
        "pfenex",
        "may",
        "also",
        "eligible",
        "receive",
        "royalty",
        "net",
        "product",
        "sale",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}